Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches

Cognitive impairment in patients with Parkinson’s disease (PD) is one of the commonest and most disabling non-motor manifestations during the course of the disease. The clinical spectrum of PD-related cognitive impairment includes subjective cognitive decline (SCD), mild cognitive impairment (MCI) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Degirmenci, Yildiz, Angelopoulou, Efthalia, Georgakopoulou, Vasiliki Epameinondas, Bougea, Anastasia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608778/
https://www.ncbi.nlm.nih.gov/pubmed/37893474
http://dx.doi.org/10.3390/medicina59101756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608778/
https://www.ncbi.nlm.nih.gov/pubmed/37893474
http://dx.doi.org/10.3390/medicina59101756

Ejemplares similares